当前位置:首页 - 行情中心 - 力生制药(002393) - 财务分析 - 现金流量表

力生制药

(002393)

  

流通市值:57.67亿  总市值:59.35亿
流通股本:2.50亿   总股本:2.58亿

现金流量表

报告期2025-12-312025-09-302025-06-302025-03-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,457,801,783.561,008,713,306.08673,934,084.11285,497,465.11
  收到的税费返还27,273.8315,589.0615,589.0615,589.06
  收到其他与经营活动有关的现金138,292,035.05113,108,957.1691,600,684.5925,372,994.11
  经营活动现金流入小计1,596,121,092.441,121,837,852.3765,550,357.76310,886,048.28
  购买商品、接受劳务支付的现金411,270,616.98278,438,685.88187,109,163.897,027,390.25
  支付给职工以及为职工支付的现金280,533,714.05188,895,414.86127,605,321.3173,822,258.16
  支付的各项税费190,205,081.14160,625,209.47120,308,589.8236,839,325.91
  支付其他与经营活动有关的现金466,615,029.56369,058,945.53260,696,456.71104,174,685.54
  经营活动现金流出小计1,348,624,441.73997,018,255.74695,719,531.64311,863,659.86
  经营活动产生的现金流量净额247,496,650.71124,819,596.5669,830,826.12-977,611.58
二、投资活动产生的现金流量:
  收回投资收到的现金3,110,464,041.672,310,230,0001,934,975,0001,243,674,000
  取得投资收益收到的现金204,356,90439,226,845.8513,074,424.346,118,675.82
  处置固定资产、无形资产和其他长期资产收回的现金净额2,930,780.8943,442.0837,442.0826,553.28
  处置子公司及其他营业单位收到的现金净额-00-
  收到的其他与投资活动有关的现金-50,000,00050,000,000-
  投资活动现金流入小计3,317,751,726.562,399,500,287.931,998,086,866.421,249,819,229.1
  购建固定资产、无形资产和其他长期资产支付的现金37,459,304.5917,353,946.9412,173,916.335,456,430.37
  投资支付的现金3,440,575,0002,725,230,0002,269,975,0001,143,674,000
  取得子公司及其他营业单位支付的现金6,991,8556,991,855--
  支付其他与投资活动有关的现金12,50012,50013,281.0912,500
  投资活动现金流出小计3,485,038,659.592,749,588,301.942,282,162,197.421,149,142,930.37
  投资活动产生的现金流量净额-167,286,933.03-350,088,014.01-284,075,331100,676,298.73
三、筹资活动产生的现金流量:
  吸收投资收到的现金68,681,90061,104,30061,104,30061,104,300
  取得借款收到的现金24,314,642.8325,000,00010,000,000-
  收到其他与筹资活动有关的现金1,052,017.971,052,017.971,052,017.97-
  筹资活动现金流入小计94,048,560.887,156,317.9772,156,317.9761,104,300
  偿还债务支付的现金39,750,00039,750,00039,750,00010,000,000
  分配股利、利润或偿付利息支付的现金97,001,999.5197,437,481.6192,804,490.88704,431.61
  支付其他与筹资活动有关的现金95,433,152.9792,620,020.7791,745,891.7393,290,782.5
  筹资活动现金流出小计232,185,152.48229,807,502.38224,300,382.61103,995,214.11
  筹资活动产生的现金流量净额-138,136,591.68-142,651,184.41-152,144,064.64-42,890,914.11
四、汇率变动对现金及现金等价物的影响-2,566.09-2,566.09-441.85-
五、现金及现金等价物净增加额-57,929,440.09-367,922,167.95-366,389,011.3756,807,773.04
  加:期初现金及现金等价物余额1,595,165,053.711,595,165,053.711,595,165,053.711,595,165,053.71
  期末现金及现金等价物余额1,537,235,613.621,227,242,885.761,228,776,042.341,651,972,826.75
补充资料:
  净利润422,726,444.63-345,337,466.37-
  资产减值准备20,080,500.19-16,435,037.58-
  固定资产和投资性房地产折旧67,037,821.49-33,682,424.91-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧67,037,821.49-33,682,424.91-
  无形资产摊销8,270,050.87-4,085,575.62-
  长期待摊费用摊销651,149.45-195,215.94-
  处置固定资产、无形资产和其他长期资产的损失-249,613.79-2,244,788.65-
  固定资产报废损失93,446.42---
  公允价值变动损失-2,105,592.51-197,794.77-
  财务费用2,268,891.66-1,284,520.32-
  投资损失-324,770,617.56--315,674,594.19-
  递延所得税-26,190,687.36---
  其中:递延所得税资产减少-25,144,691.32---
    递延所得税负债增加-1,045,996.04---
  存货的减少11,279,585.29--2,650,403.49-
  经营性应收项目的减少78,873,514.42--29,321,854.53-
  经营性应付项目的增加-30,470,666.72-11,867,838.06-
  其他15,866,320.98---
  现金的期末余额1,537,235,613.62-1,228,776,042.34-
  减:现金的期初余额1,595,165,053.71-1,595,165,053.71-
  现金及现金等价物的净增加额-57,929,440.09--366,389,011.37-
公告日期2026-03-252025-10-242025-08-222025-04-25
审计意见(境内)标准无保留意见
TOP↑